These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16150244)

  • 1. Positron emission tomography/computed tomography imaging of head and neck tumors: an atlas.
    Graham MM; Menda Y
    Semin Nucl Med; 2005 Oct; 35(4):220-52. PubMed ID: 16150244
    [No Abstract]   [Full Text] [Related]  

  • 2. Head and neck: normal variations and benign findings in FDG positron emission tomography/computed tomography imaging.
    Højgaard L; Berthelsen AK; Loft A
    PET Clin; 2014 Apr; 9(2):141-5. PubMed ID: 25030278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Head and neck neoplasms--combination PET/CT is better than a single approach].
    Rofo; 2005 Oct; 177(10):1345. PubMed ID: 16170700
    [No Abstract]   [Full Text] [Related]  

  • 4. Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers.
    Menda Y; Graham MM
    Semin Nucl Med; 2005 Oct; 35(4):214-9. PubMed ID: 16150243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based guideline recommendations on the use of positron emission tomography imaging in head and neck cancer from Ontario and guidelines in general--some observations.
    Wong WL; Ross P; Corcoran M
    Clin Oncol (R Coll Radiol); 2013 Apr; 25(4):242-5. PubMed ID: 23422786
    [No Abstract]   [Full Text] [Related]  

  • 6. Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck.
    Zimmer LA; Branstetter BF; Nayak JV; Johnson JT
    Laryngoscope; 2005 Nov; 115(11):2029-34. PubMed ID: 16319618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear medicine imaging studies in the diagnosis of head and neck disease.
    Chiang S
    Oral Maxillofac Surg Clin North Am; 2014 May; 26(2):239-45. PubMed ID: 24794268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG-PET staging of head and neck cancer--can improved imaging lead to improved treatment?
    Schwartz DL; Macapinlac HA; Weber RS
    J Natl Cancer Inst; 2008 May; 100(10):688-9. PubMed ID: 18477798
    [No Abstract]   [Full Text] [Related]  

  • 9. [The value of PET-CT imaging in malignant tumours of the head and neck].
    Balink H; Krabbe CA; de Visscher JG
    Ned Tijdschr Geneeskd; 2007 May; 151(21):1167-72. PubMed ID: 17557755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.
    Quon A; Fischbein NJ; McDougall IR; Le QT; Loo BW; Pinto H; Kaplan MJ
    J Nucl Med; 2007 Jan; 48 Suppl 1():58S-67S. PubMed ID: 17204721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head and neck cancer: dedicated FDG PET/CT protocol for detection--phantom and initial clinical studies.
    Yamamoto Y; Wong TZ; Turkington TG; Hawk TC; Coleman RE
    Radiology; 2007 Jul; 244(1):263-72. PubMed ID: 17495174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of positron emission tomography/computed tomography in edge delineation of gross tumor volume for head and neck cancers.
    Ashamalla H; Guirgius A; Bieniek E; Rafla S; Evola A; Goswami G; Oldroyd R; Mokhtar B; Parikh K
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):388-95. PubMed ID: 17324530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What does PET imaging add to conventional staging of head and neck cancer patients?
    Pohar S; Brown R; Newman N; Koniarczyk M; Hsu J; Feiglin D
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):383-7. PubMed ID: 17379443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 18FFDG PET/CT in the treatment of head and neck cancers: posttherapy evaluation and pitfalls.
    Kapoor V; Fukui MB; McCook BM
    AJR Am J Roentgenol; 2005 Feb; 184(2):589-97. PubMed ID: 15671385
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of positron emission tomography in the management of head and neck cancer in the molecular therapy era.
    Garcia C; Flamen P
    Curr Opin Oncol; 2008 May; 20(3):275-9. PubMed ID: 18391626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of 18-fluorine fluorodeoxyglucose positron emission tomography-CT imaging in head and neck tumors].
    Li XP; Liang Y; Liu X; Wang QS; Wu HB
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 May; 39(5):298-301. PubMed ID: 15338869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer.
    Schinagl DA; Vogel WV; Hoffmann AL; van Dalen JA; Oyen WJ; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1282-9. PubMed ID: 17967318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head and neck cancer.
    Walden MJ; Aygun N
    Semin Roentgenol; 2013 Jan; 48(1):75-86. PubMed ID: 23158052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head and Neck Cancer and PET/Computed Tomography.
    Subramaniam RM
    PET Clin; 2022 Apr; 17(2):xi. PubMed ID: 35277347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.